Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Xigduo XR approved in China for adults with type-2 diabetes – AstraZeneca

Written by | 4 Jul 2023

AstraZeneca’s Xigduo XR (dapagliflozin and metformin hydrochloride extended-release), a once-daily fixed-dose combination, has been approved by China’s National Medical Products Administration (NMPA) for the treatment of adults with… read more.

Decreased influenza prevalence potentially associated with public health measures against COVID-19

Written by | 1 Jan 2023

A recent study provides preliminary evidence of the long-term relationship between prevention and control measures and influenza transmission in China during the COVID-19 pandemic, accounting for the impact… read more.

Orpathys approved in China for patients with lung cancer and MET gene alterations – AstraZeneca + HUTCHMED

Written by | 3 Jul 2021

AstraZeneca and HUTCHMED’s Orpathys (savolitinib) has been granted conditional approval in China to treat patients with non-small cell lung cancer (NSCLC) with MET exon 14 skipping alterations who… read more.

Medical staff plagued by insomnia during pandemic

Written by | 25 Nov 2020

Article written by Gary Finnegan More than a third of medical staff suffered insomnia during the COVID-19 epidemic in China, according to a new study.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.